Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2026-02-23 @ 6:25 AM
Study NCT ID:
NCT01260103
Status:
WITHDRAWN
Last Update Posted:
2017-07-26
First Post:
2010-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
Sponsor:
Burzynski Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BRI-BT-54
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None